Skip to content
V-Biognostics
Toggle menu
  • About
  • Contact
  • Products
    • Osteocalcin (1-49) Human (Synthetic)
    • Antibiotics
      • Amphotericin B (Fungizone)
      • Bestatin (Ubenimex)
      • Bleomycin Sulfate
      • Brefeldin A
      • Daptomycin
      • G418, Sulfate
      • Mitomycin C
      • Thiostrepton
      • Valinomycin
    • Protease Inhibitors 1
      • AEBSF
      • Alafosfalin (Synthetic)
      • ALLN (Calpain Inh. I)
      • ALLM (Calpain Inh. II)
      • Amastatin, HCl
      • Antipain, 2HCl
      • Bestatin, HCl
      • Calpain Inh. III
      • Calpeptin
    • Protease Inhibitors 2
      • E-64 (Synthetic)
      • E-64d
      • Elastase Inh. I
      • Leupeptin, HCl
      • Leupeptin, Hemisulfate
      • MG-132
      • Pepstatin A
      • Phosphoramidon
      • RG108
      • TLCK, HCl
  • GERBU
    • GERBU Esterquat Product List
    • GERBU Adjuvant Product List
    • GERBU Adjuvant Introduction
    • GERBU Adjuvants Product Manuals
  • Articles
  • Email Logo

Category: News

August 22, 2019News

The BIO Investor Forum Links Promising Early-Stage Technologies with an Active Investor Network

BIOtech Now Nareg Sagherian As the biopharma industry has gained traction on new drug approvals throughout 2019, the financial dollars have followed […]

August 21, 2019News

New Coalition to Raise Awareness of Antimicrobial Resistance Threat, Call for Urgent Solutions

BIOtech Now Andrew Segerman The Biotechnology Innovation Organization (BIO), leading scientists, public policy experts, and industry leaders today announced the launch of […]

August 20, 2019News

BIO’s Jim Greenwood Talks Pricing, Policy and Science on CSPAN

BIOtech Now Andrew Segerman BIO’s Jim Greenwood joined CSPAN’s Washington Journal for a conversation about drug pricing, the latest proposals being considered […]

August 6, 2019News

Biotech Leaders Warn: Shortsighted Policies Threaten Miracle Breakthroughs

BIOtech Now Andrew Segerman Writing for STAT News, Paul Hastings – CEO of Nkarta Therapeutics and Vice Chair of BIO’s Board – […]

August 5, 2019News

Why Are Patients Facing Higher Costs When They Go to the Pharmacy?

BIOtech Now Andrew Segerman BIO is out with a new whiteboard video that explores why more and more patients are facing higher […]

July 31, 2019News

Technology to Fight Malaria, Zika, and Other Mosquito-Related Diseases Is Being Blocked. Why?

BIOtech Now Josh Falzone Every year, mosquitos infect 500 million people with diseases and mosquito-borne illnesses claim nearly a million lives. Mosquito-related […]

July 24, 2019News

Experts Weigh In on the Dangers of Importing Foreign Price Controls

BIOtech Now Andrew Segerman Experts recently gathered on Capitol Hill to discuss how importing foreign price controls will lead to less innovation […]

July 19, 2019News

New Videos Show How “Fail First” Policies Can Fail Patients

BIOtech Now BIOtechNOW Editor Continued access to a stable treatment can make all the difference for patients with chronic illnesses like arthritis, […]

July 16, 2019News

Rare Disease Drug Development Increases but Challenges Remain

BIOtech Now Andrew Segerman In a recent study published by Tufts University, researchers found that rare disease drug development is now one […]

June 27, 2019News

Greenwood: A Critical Medicare Policy Has Been Delayed. Let’s Use This Opportunity to Get It Right.

BIOtech Now Andrew Segerman In a piece for Morning Consult, BIO’s Jim Greenwood writes that while CAR-T cell therapies are changing the […]

June 26, 2019News

A Sustainable Movement to Curb Cancer in Africa

BIOtech Now admin In just two years, BIO Ventures for Global Health (BVGH) has made significant progress in responding to the growing […]

June 25, 2019News

New BIO White Paper: Incorporating Real-World Evidence Within the Label of an FDA-Approved Drug

BIOtech Now Sesquile Ramon In today’s increasingly connected world, health care researchers have access to previously unimaginable troves of data about the […]

June 20, 2019News

The DISARM Act Can Help Fix the Broken Antibiotics Market

BIOtech Now Andrew Segerman In his a recent piece for Bloomberg, reporter Robert Langreth paints a harrowing picture of the quickly deteriorating […]

June 13, 2019News

AI Helps Unravel Mystery of Neurological Disorders

BIOtech Now Jeremy Isenberg Neurological disorders are estimated to affect up to 1 billion people around the world—including nearly 100 million Americans—with […]

June 6, 2019News

BIO 2019 Wraps Up in Philadelphia

BIOtech Now Theresa Brady “The world is beginning to grasp that we’ve entered the dawn of a golden age of medicine. It’s […]

June 5, 2019News

U.S. as a Global Leader for Patient Access

BIOtech Now BIOtechNOW Editor Some 95 percent of cancer drugs launched around the globe are available in the U.S. Given that the […]

June 4, 2019News

Opioids: Changing the Paradigm of Treating Pain and Addiction—One Year Later

BIOtech Now Jeremy Isenberg Drug overdose deaths, including those involving opioids, reached 42,000 in 2016 (CDC), prompting a national response from the […]

June 3, 2019News

New Approaches to Reimbursement for Gene Therapy: What Can We Learn from Models Currently in Practice?

BIOtech Now Theresa Brady It’s obvious that cost presents a major burden for patient access to gene therapy. The recent approval of […]

May 30, 2019News

BIO 2019 Innovation Zone Company Snapshot: Litron Laboratories

BIOtech Now Andrew Segerman The next big medical breakthrough is on the horizon and all it takes is one idea, one vision, […]

May 24, 2019News

BIO 2019 Innovation Zone Company Snapshot: HealthRhythms, Inc.

BIOtech Now Andrew Segerman The next big medical breakthrough is on the horizon and all it takes is one idea, one vision, […]

Posts navigation

< 1 … 31 32 33 … 48 >
Partnering with:   Quartett GERBU Adjuvants

V-BIOGNOSTICS, "Ingredients For Life" is a BioTech company devoted to research in life science reagents worldwide. We source difficult to find biochemicals for the advancement in research of antibody production, Immunohistochemistry, drug development, molecular biology, cell biology, cancer research, Immunotherapy, Oncology, drug discovery, and agricultural biotechnology. We work hard for speedy processing and delivery of your products and at very competitive pricing offering you a high quality alternative to big pharma for your sourcing and manufacturing needs.

D&B VERIFIED Seal

We Supply the highest quality protease inhibitors, antibiotics, and Adjuvants including: Bestatin HCl, Leupeptin Hemisulfate / Hydrochloride, AEBSF, G418, Elastatinal, E-64, Pepstatin, Calpain, Bleomycin Sulfate, Proteinase K, MG-132, ALLM, ALLN, Antipain, Anti-Human Rabbit IgG, GERBU Monoclonal/Polyclonal Adjuvant, synthetic and custom synthesis. Please Contact Us or visit our Products, About, or Terms pages for more information.

Biotech Articles

  • New ‘asthma-on-a-chip’ technology opens the door to future treatments
  • Breast milk nutrient shapes immune development in mice
  • A targeted paper shredder for the genome: new CRISPR tech tears up diseased cells’ DNA
  • The biotech bi-weekly: partnerships facilitating antibody discovery and AI drug development
  • New gene therapy reverses Fragile X deficits in preclinical model
  • May I have your attention, please: ancient neurons hold ADHD clues
© 2026 V-Biognostics. Proudly powered by Sydney